Paper4333399
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.
Raisz LG and 3 others. Science, 1972. Cited by 589 papers, by iCite.
Cite this record
ConductScience Library. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Papers, record 4333399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4333399
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Resorption | Major topic |
| Cholecalciferol | Major topic |
| Animals | |
| Autoradiography | |
| Bone and Bones | |
| Calcium | |
| Calcium Isotopes | |
| Culture Techniques | |
| Hydroxycholecalciferols | |
| Kidney | |
| Rats | |
| Stimulation, Chemical | |
| Tritium |
Source PubMed
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 589 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41828612 | Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828612 | PubMed |
| 39683587 | Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy. | Nutrients | 2024 | https://conductscience.org/library/papers/39683587 | PubMed |
| 38102330 | Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/38102330 | PubMed |
| 35967790 | Quantification of Vitamins, Minerals, and Amino Acids in Black Walnut (Juglans nigra). | Front Nutr | 2022 | https://conductscience.org/library/papers/35967790 | PubMed |
| 33657451 | Natural medicine delivery from biomedical devices to treat bone disorders: A review. | Acta Biomater | 2021 | https://conductscience.org/library/papers/33657451 | PubMed |
| 33466312 | Tranexamic Acid Promotes Murine Bone Marrow-Derived Osteoblast Proliferation and Inhibits Osteoclast Formation In Vitro. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33466312 | PubMed |
| 33081124 | Metabolomic Associations with Serum Bone Turnover Markers. | Nutrients | 2020 | https://conductscience.org/library/papers/33081124 | PubMed |
| 33007883 | Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. | Nutrients | 2020 | https://conductscience.org/library/papers/33007883 | PubMed |
| 32987399 | The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo. | Endocrinology | 2020 | https://conductscience.org/library/papers/32987399 | PubMed |
| 28370465 | Pharmacologic Calcitriol Inhibits Osteoclast Lineage Commitment via the BMP-Smad1 and IκB-NF-κB Pathways. | J Bone Miner Res | 2017 | https://conductscience.org/library/papers/28370465 | PubMed |
| 27050092 | Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis. | PLoS One | 2016 | https://conductscience.org/library/papers/27050092 | PubMed |
| 26424141 | Vitamin D and Clinical Outcomes in Dialysis. | Semin Dial | 2015 | https://conductscience.org/library/papers/26424141 | PubMed |
| 25931412 | The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). | Endocrine | 2015 | https://conductscience.org/library/papers/25931412 | PubMed |
| 25446885 | Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass. | J Steroid Biochem Mol Biol | 2015 | https://conductscience.org/library/papers/25446885 | PubMed |
| 24876121 | Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis. | J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/24876121 | PubMed |
| 24605212 | Vitamin D endocrine system and osteoclasts. | Bonekey Rep | 2014 | https://conductscience.org/library/papers/24605212 | PubMed |
| 23566108 | Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. | J Vet Emerg Crit Care (San Antonio) | 2013 | https://conductscience.org/library/papers/23566108 | PubMed |
| 23411428 | Calcium absorption response to cholecalciferol supplementation in hemodialysis. | Clin J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23411428 | PubMed |
| 22193236 | Vitamin D therapy in chronic kidney disease and end stage renal disease. | Clin J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22193236 | PubMed |
| 20495792 | Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats. | Calcif Tissue Int | 2010 | https://conductscience.org/library/papers/20495792 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4333399
GET https://conductscience.org/api/papers/v1/4333399/cited_by?page=2